Clinical Study Protocol
1.0.0-ballot2 - STU 1 Ballot2
Clinical Study Protocol
1.0.0-ballot2 - STU 1 Ballot2
This page is part of the Pharmaceutical Clinical Trial Protocols (v1.0.0-ballot2: STU 1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
| Page standards status: Informative |
Language: en
Profile: M11 Research Study Profile
M11 Research Study Extension
- originalProtocol: Protocol Not Amended
- versionDate: 2026-01-14
identifier: Sponsor Identifier/JPMA001 (use: usual, )
version: 2.0
title: A Multicenter, 52-week, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Co-administration of JPMA001 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control Treated With Oral Hypoglycemic Drugs as a Single Agent
| Type | Value |
| Short title | Administration for patients with type 2 diabetes |
date: 2026-01-14
status: Active
phase: Phase III Trial
IG © 2026+ HL7 International / Biomedical Research and Regulation.
Package hl7.fhir.uv.clinical-study-protocol#1.0.0-ballot2 based on FHIR 6.0.0-ballot3.
Generated
2026-04-09
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change